Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Advances in Rheumatology (London, England)|November 22, 2025
Comparison of the immunogenicity and safety among COVID-19 vaccines ChadOx-1, CoronaVac and BNT162b2 in systemic lupus erythematosus (SLE) patients: a prospective cohortPriscila Dias Cardoso Ribeiro, Flavia Maria Matos Melo Campos Peixoto, Edgard Torres Dos Reis-Neto, et al.
Advances in Rheumatology (London, England)|May 3, 2022
Factors associated with hospitalizations for Covid-19 in patients with rheumatoid arthritis: data from the Reumacov Brazil registryAna Paula Monteiro Gomides, Cleandro Pires de Albuquerque, Licia Maria Henrique da Mota, et al.
Advances in Rheumatology (London, England)|November 24, 2022
COVID-19 was not associated or trigger disease activity in spondylarthritis patients: ReumaCoV-Brasil cross-sectional dataClaudia Diniz Lopes Marques, Sandra Lúcia Euzébio Ribeiro, Cleandro P Albuquerque, et al.
Vaccines|September 28, 2024
Predictors of Hospitalization in Breakthrough COVID-19 among Fully Vaccinated Individuals with Immune-Mediated Rheumatic Diseases: Data from SAFER-StudyDébora Cerqueira Calderaro, Valéria Valim, Gilda Aparecida Ferreira, et al.
Vaccines|January 8, 2025
Immunogenicity and Safety According to Immunosuppressive Drugs and Different COVID-19 Vaccine Platforms in Immune-Mediated Disease: Data from SAFER CohortKetty Lysie Libardi Lira Machado, Ana Paula Neves Burian, Olindo Assis Martins-Filho, et al.
Advances in Rheumatology (London, England)|January 18, 2022
Guidelines on COVID-19 vaccination in patients with immune-mediated rheumatic diseases: a Brazilian Society of Rheumatology task forceAnna Carolina Faria Moreira Gomes Tavares, Ana Karla Guedes de Melo, Vítor Alves Cruz, et al.
Advances in Rheumatology (London, England)|April 26, 2024
To be or not to B27 positive: implications for the phenotypes of axial spondyloarthritis outcomes. Data from a large multiracial cohort from the Brazilian Registry of SpondyloarthritisGustavo Gomes Resende, Carla Goncalves Schahin Saad, Claudia Diniz Lopes Marques, et al.
Advances in Rheumatology (London, England)|November 20, 2025
Reply to the letter on "Brazilian guidelines for the management of tuberculosis infection in immune-mediated inflammatory diseases: is retesting in latent tuberculosis screening appropriate and safe?"Viviane Angelina de Souza, Ana Luiza Mendes Amorim Caparroz, Virginia Fernandes Moça Trevisani, et al.
Advances in Rheumatology (London, England)|March 21, 2025
Brazilian recommendations for the management of tuberculosis infection in immune-mediated inflammatory diseasesViviane Angelina de Souza, Ana Luiza Mendes Amorim Caparroz, Virginia Fernandes Moça Trevisani, et al.
Frontiers in Immunology|December 3, 2025
Immunogenicity and safety to SARS-Cov-2 vaccination in patients with systemic vasculitisErika Biegelmeyer, Mariana de Freitas Aguiar, Priscila Dias Cardoso Ribeiro, et al.
Pageof 6